欧洲皮肤病论坛2020年体外光分离置换疗法使用指南更新(第一部分)
欧洲皮肤病论坛(EDF)基于已发表文献和专家共识,更新了体外光分离置换疗法(ECP)的临床应用指南。第一部分覆盖皮肤T细胞淋巴瘤、慢性移植物抗宿主病和急性移植物抗宿主病,提供当前最全面的专家推荐。
要点
- ECP可用于皮肤T细胞淋巴瘤的治疗。
- ECP可用于慢性及急性移植物抗宿主病。
- 指南基于文献与专家共识制定。
核心结论
- 2020年更新指南基于现有文献和专家共识,为ECP的应用提供了当前最全面的专家推荐。
研究设计与样本
- 欧洲皮肤病论坛(EDF)按照其认可并批准的指南制定方法,组织皮肤科及相关领域专家共同制定。
主要发现
- 指南分为两部分,第一部分覆盖皮肤T细胞淋巴瘤、慢性移植物抗宿主病和急性移植物抗宿主病。
关键数值与推荐
- 指南推荐条款涉及皮肤T细胞淋巴瘤、慢性移植物抗宿主病和急性移植物抗宿主病。
临床怎么用
- 临床可依据该指南在皮肤T细胞淋巴瘤、慢性及急性移植物抗宿主病中应用ECP。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Following the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma published in 1983, this technology has received continued use and further recognition for additional earlier as well as refractory forms. After the publication of the first guidelines for this technology in the JEADV in 2014, this technology has maintained additional promise in the treatment of other severe and refractory conditions in a multi-disciplinary setting. It has confirmed recognition in well-known documented conditions such as graft-versus-host disease after allogeneic bone marrow transplantation, systemic sclerosis, solid organ transplant rejection including lung, heart and liver and to a lesser extent inflammatory bowel disease. MATERIALS AND METHODS: In order to further provide recognized expert practical guidelines for the use of this technology for all indications, the European Dermatology Forum (EDF) again proceeded to address these questions in the hands of the recognized experts within and outside the field of dermatology. This was done using the recognized and approved guidelines of EDF for this task. All authors had the opportunity to review each contribution as it was added. RESULTS AND CONCLUSION: These updated 2020 guidelines provide at present the most comprehensive available expert recommendations for the use of extracorporeal photopheresis based on the available published literature and expert consensus opinion. The guidelines are divided in two parts: PART I covers cutaneous T-cell lymphoma, chronic graft-versus-host disease and acute graft-versus-host disease while PART II will cover scleroderma, solid organ transplantation, Crohn's disease, use of ECP in paediatrics practice, atopic dermatitis, type 1 diabetes, pemphigus, epidermolysis bullosa acquisita and erosive oral lichen planus.
引用
- Knobler R, Arenberger P, Arun A, et al. European dermatology forum - updated guidelines on the use of extracorporeal photopheresis 2020 - part 1. J Eur Acad Dermatol Venereol. 2020. PMID: 33025659. doi:10.1111/jdv.16890
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。